海达舍画阁药业

Haida Shehuage Pharmaceutical Co., Ltd., founded in 2009 and headquartered in Shenzhen's Shenshan Special Cooperation Zone, is a national high-tech pharmaceutical enterprise integrating drug research and development, manufacturing, and marketing. The company operates multiple GMP-certified production lines, including oral liquids, tablets, capsules, granules, and traditional Chinese medicine extraction facilities. Its product portfolio spans both modern generic drugs and proprietary traditional Chinese medicines, notably featuring 'Sanwei Huayu Capsules' (三味化瘀胶囊), a patented herbal formulation used as an adjuvant therapy for non-small cell lung cancer. Additionally, the company manufactures widely distributed generic products such as ambroxol + clenbuterol oral solution (氨溴特罗口服溶液) for respiratory conditions and memantine oral solution (美金刚口服溶液) for Alzheimer's disease.